期刊文献+

B型脑钠肽在慢性阻塞性肺疾病中的临床价值观察

The Value of B- type Natriuretic Peptide( BNP) in Clinical Application on Chronic Obstructive Pulmonary Disease
暂未订购
导出
摘要 目的探讨B型脑钠肽(BNP)在慢性阻塞性肺疾病(COPD)中的临床观察。方法选取2011年6月—2013年2月COPD急性发作入我院住院的60例患者,检测60例COPD患者急性发作期血浆BNP值,分析比较发生左心室收缩功能不全组与未发生组BNP水平的区别。结果发生左心室收缩功能不全组BNP水平为(679.6±274.5)pg/ml,未发生组BNP水平为(251.8±134.7)pg/ml,组间比较,差异有统计学意义(P<0.05)。结论BNP对于COPD急性发作期的患者发现左心功能不全有着肯定的作用。 Objective To investigate the clinical efficacy of B - type natriuretic peptide (BNP) in the treatment of chronic obstructive pulmonary disease (COPD). Methods A total of 60 patients with acute exacerbation of COPD who were admitted to our hospital from June 2011 to February 2013, were selected as study subjects to measure plasma BNP levels. Then the plasma BNP levels of patients with left ventricular systolic dysfunction was compared with the level of patients without left ven- tricular systolic dysfunction. Results The plasma BNP levels of patients with left ventricular systolic dysfunction ( 679. 6 ±274. 5 pg/ml) was higher than the patients' without left ventricular systolic dysfunction (251.8± 134. 7 pg/ml). The differ- ence was statistically significant (P 〈 0. 05). Conclusion Plasma BNP may be a influence factor of left ventricular systolic dysfunction inpatients with acute exacerbation of COPD.
作者 梁艳
出处 《临床合理用药杂志》 2014年第6期108-109,共2页 Chinese Journal of Clinical Rational Drug Use
关键词 肺疾病 慢性阻塞性 心室功能障碍 B型脑钠肽 Pulmonary disease, chronic obstructive ventricular dysfunction, left B - type natriuretic peptide (BNP)
  • 相关文献

参考文献7

  • 1Braunwald E. Biomarkers in heart failure[J].{H}New England Journal of Medicine,2008,(02):2148-2159.
  • 2杨长春,李凯,高敏,赵海滨.B型脑钠肽在老年肺部感染患者的变化与预后的意义[J].中华医院感染学杂志,2013,23(2):251-253. 被引量:9
  • 3林胜辉,姚炳炬.快速测定脑钠肽在呼吸困难患者的临床价值[J].中国老年保健医学,2012,10(4):61-62. 被引量:1
  • 4随华,刘纯.脑钠肽与内分泌疾病[J].国际内分泌代谢杂志,2006,26(3):181-183. 被引量:11
  • 5陆再英;钟南山.内科学[M]北京:人民卫生出版社,200962-68.
  • 6Le Jemtel TH,Padeletti M,Jelic S. Diagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure[J].{H}Journal of the America College of Cardiology,2007,(02):171-180.
  • 7Jourdain P,Jondeau G,Funck F. Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure:the STARS-BNP Multicenter Study[J].{H}Journal of the America College of Cardiology,2007,(16):1733-1739.

二级参考文献34

  • 1中华医学会心血管病学分会 中华心血管病杂志编辑委员会.慢性心力衰竭诊断治疗建议.中华心血管病杂志,2007,35(12):1076-1095.
  • 2Remme WJ, Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J, 2001,22 : 1527-1560.
  • 3Lim HS, Patel JV, Nadar S, et al. Comparison of brain natriuretic peptide and left ventrieular diastolic function determined by tissue Doppler in patients with diabetes mellitus, patients with hypertension without diabetes,and in heathy subjects. Am J Cardiol, 2005,95 : 905-908.
  • 4Epshteyn V, Morrison K, Kazanegra R,et al. Utility orb type natriuretic peptide (BNP) as a screen for left ventricular dysfunction in patients with diabetes. Diabetes Care,2003,26:2081-2087.
  • 5Emerman CL.Treatment of the acute decompensatian of heart failure: efficacy and pharmacoeconomics of early initiation of therapy in the emergency department. Rev Cardiovasc Med, 2003,4 ( Suppl 7 ) : S13-S20.
  • 6Scroggins N, Edwards M, Delgado R 3rd. Increased cost effectiveness with nesiritide vs. milrinone or dobutamine in the treatment of acute decompensated heart failure. Congest Heart Fail, 2005,11 : 311-314.
  • 7Rosenkranz AC, Hood SG, Woods RL, et al. B-type natriuretic peptide prevents acute hypertrophic responses in the diabetic rat heart: importance of cyclic GMP. Diabetes, 2003,52 : 2389-2395.
  • 8Yano Y, Katsuki A, Gabazza EC, et al. Plasma brain natriuretic peptide levels in normotensive noninsulin-dependent diabetic patieuts with microalbuminuria.J Clin Endocrinol Metab, 1999,84:2353-2356.
  • 9Siebenhofer A, Ng LL, Plank J, et al. Plasma N-terminal pro-brain natriuretic peptide in type 1 diabetic patients with and without diabetic nephropathy, Diabet Med, 2003,20:535-539.
  • 10Liu C, Agnes G, Corcuff JB, et al. B-type natriuretic peptide in diabetes mellitus:the influence of chronic renal failure and meal. Diabetes Care,2005,28 : 752.

共引文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部